Raymond James & Associates Meridian Bioscience Inc Transaction History

Raymond James & Associates

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$31.15 - $33.39 $214,156 - $229,556	-6,875 Reduced 36.17%	12,133 $402,000
Q3 2022 Oct 25, 2022	BUY	$30.9 - $33.55 $198,192 - $215,189	6,414 Added 50.93%	19,008 $599,000
Q2 2022 Aug 12, 2022	BUY	$23.75 - $31.69 $26,053 - $34,763	1,097 Added 9.54%	12,594 $383,000
Q1 2022 May 11, 2022	SELL	$19.97 - $26.94 $9,405 - $12,688	-471 Reduced 3.94%	11,497 $298,000
Q4 2021 Feb 08, 2022	SELL	$17.46 - $21.61 $195,517 - $241,988	-11,198 Reduced 48.34%	11,968 $244,000
Q3 2021 Nov 02, 2021	SELL	$17.35 - $22.5 $939,728 - $1.22 Million	-54,163 Reduced 70.04%	23,166 $446,000
Q2 2021 Aug 11, 2021	SELL	$18.01 - $28.32 $217,182 - $341,510	-12,059 Reduced 13.49%	77,329 $1.72 Million
Q1 2021 May 14, 2021	SELL	$19.76 - $29.89 $127,748 - $193,238	-6,465 Reduced 6.74%	89,388 $2.35 Million
Q4 2020 Feb 12, 2021	BUY	$15.73 - $21.66 $84,422 - $116,249	5,367 Added 5.93%	95,853 $1.79 Million
Q3 2020 Nov 04, 2020	SELL	$13.54 - $26.41 $258,695 - $504,589	-19,106 Reduced 17.43%	90,486 $1.54 Million
Q2 2020 Jul 28, 2020	BUY	$7.84 - $23.29 $99,850 - $296,621	12,736 Added 13.15%	109,592 $2.55 Million
Q1 2020 Apr 21, 2020	BUY	$5.57 - $11.5 $539,487 - $1.11 Million	96,856 New	96,856 $814,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.